Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
Author:
Open Access
- 21 February 2016
- journal article
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 5 (5) , 333-335
Abstract
Hyosun Kim’s report “Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A content Analysis of FDA Warning Letters”aims to teach marketers how to avoid breaching current Food and Drug Administration (FDA) guidelines in their online drug promotion. While Kim hopes to minimise the potential for online promotion to misinform consumers and the study is carefully conducted, teaching drug marketers how to avoid the common mistakes in online drug promotion is more likely to make marketers more adept at spinning information than appropriately balancing it.Keywords
This publication has 11 references indexed in Scilit:
- Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning LettersInternational Journal of Health Policy and Management, 2015
- It's Time to Shine the Light on Direct-to-Consumer AdvertisingThe Annals of Family Medicine, 2015
- A Prompt to the Web: The Media and Health Information Seeking BehaviourPLOS ONE, 2012
- Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?2011
- The Cost-Effectiveness of Direct-to-Consumer Advertising for Prescription DrugsMedical Care Research and Review, 2009
- The informative and persuasive components of pharmaceutical promotionInternational Journal of Advertising, 2009
- Direct‐to‐consumer advertising under the radar: the need for realistic drugs policy in AustraliaInternal Medicine Journal, 2007
- Direct-to-consumer advertising of prescription medicines: A systematic review of the evidence from the perspective of the consumerJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2007
- DIRECT‐TO‐CONSUMER ADVERTISING (DTCA) OF PHARMACEUTICALS: AN UPDATED REVIEW OF THE LITERATURE AND DEBATE SINCE 20031Economic Affairs, 2006
- The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debateInternational Journal of Advertising, 2004